Vitamin B12 deficiency is relatively common, especially among older populations
A Massachusetts Eye and Ear study found that: Patients with type 2 diabetes prescribed semaglutide were about 4 times more likely to develop NAION than those on other diabetes medications Patients who were overweight or obese and were prescribed semaglutide were over 7 times more likely to develop NAION than those on other weight-loss medications Because the warning labels on these medications may not have mentioned the risk of NAION, anyone who developed vision loss or blindness after taking Ozempic may be able to pursue compensation from a NAION semaglutide lawsuit
Ingredients: Cocos Nucifera Oil, Sodium Hydroxide, Olea Europaea Fruit Oil, Sodium Lactate, Niacinamide, Lactic Acid, Glycolic Acid, Kojic Acid, Glutathione, Alpha Arbutin, Glycerin, Menthol, Bearberry Extract, Sakura Extract, Parfum
Common symptoms from GLP-1 use include nausea, vomiting, gas, bloating, loss of appetite, constipation and diarrhea